2016 RANK: 18
Fiscal year ending: Dec. 31, 2016
R&D Spend: $322,638,080
Anna Maria Braun, president, Asia Pacific; Annette Beller, CFO; Heinz-Walter Große, chairman, chief HR officer; Meinrad Lugan, president, hospital care, OPM; Caroll Neubauer, chairman & CEO, B. Braun Medical; Markus Strotmann, president, Avitum; Joachim Schulz, chairman, Aesculap; Bruce Heugel, SVP & CFO, B. Braun Medical; Rob Albert, SVP & chief marketing officer, B. Braun Medical; Joe Grispo Jr., SVP & chief sales officer, B. Braun Medical; Frank Katona, SVP & COO, B. Braun Medical; Cathy Codrea, SVP, general counsel & chief compliance officer, B. Braun Medical; Dr. Wes Cetnarowski, SVP, scientific affairs & CMO, B. Braun Medical
B. Braun has seen a flurry of product releases this year, launching its Easypump home infusion app, Diacap Pro Dialyzer, Protosan wound gel, Actreen urological mini catheters, the Docit and HubScrub sterilization devices and its Flow Collector ostomy device.
B. Braun also announced the integration of its Outlook large-volume infusion pumps with Iatric Systems Accelero Connect software, clearing the device to communicate with a number of electronic health record systems.
The company has also continued its focus on partnership, collaboration and profitability. Braun and Christie Medical said they plan to combine the VeinViewer system with Braun’s line of IV products to enhance the ease and safety of peripheral IV catheters.
You may also like: